Question 1

What is the catalog number for Cathepsin K Blocking Peptide?

Accepted Answer

The catalog number for Cathepsin K Blocking Peptide is MBS8235234.

Question 2

What sizes are available for Cathepsin K Blocking Peptide?

Accepted Answer

Cathepsin K Blocking Peptide is available in the following size(s): 1 mg, 5 mg, 5x 5 mg.

Question 3

How many pack sizes does Cathepsin K Blocking Peptide come in?

Accepted Answer

Cathepsin K Blocking Peptide is available in 3 different pack sizes.

Question 4

Is Cathepsin K Blocking Peptide in stock?

Accepted Answer

Cathepsin K Blocking Peptide is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What buffer is this product supplied in?

Accepted Answer

The formulation or storage buffer is listed on the product datasheet. If you require a carrier-free or custom formulation, contact us before ordering, as this may involve a made-to-order production timeline.

Question 6

What dilution range is recommended for immunohistochemistry (IHC) with this antibody?

Accepted Answer

A starting IHC dilution range is listed on the datasheet, but should be optimized for your specific tissue type and staining protocol.

Question 7

Can I request a Safety Data Sheet (SDS) for this product?

Accepted Answer

Yes, safety data sheets are available for hazardous or chemically classified products and can be provided on request or downloaded from the product page.

Cathepsin K Blocking Peptide

Product Specifications

Gene Name

NCBI Gene ID

Reactivity

Storage Conditions

Other Gene Names

Short Name

Other Product Names

NCBI GI Number

NCBI Accession Number

NCBI GB Accession Number

Uniprot Accession Number

Available Sizes

Frequently Asked Questions

Explore Other Products

Naphthalene-2-sulfonic Acid Hydrate

CYBC1 (NM_001033046) Human Over-expression Lysate

Geldanamycin: Biotin

DCP1B Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI2D8]

PARK7 (NM_007262) Human Over-expression Lysate

PCDHGA7 Human Gene Knockout Kit (CRISPR)